China Medical System Holdings (STU:2M7C) Shareholder Yield % : 3.67% (As of Dec. 2025) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2M7C China Medical System Holdings Ltd STU:2M7C
76 GF Score
Price €1.32
GF Value €1.36
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is China Medical System Holdings Shareholder Yield %?

China Medical System Holdings STU:2M7C +2.33% 76 Shareholder Yield % is 3.67% as of Dec. 2025, which is 8% below its 10-year median of 4.00. GuruFocus rates STU:2M7C with a GF Score™ of 76/100 and a GF Value™ of €1.36 (Fairly Valued). The stock has 3 warning signs investors should review. Among 971 Drug Manufacturers companies, China Medical System Holdings ranks better than 74.87% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, China Medical System Holdings's Shareholder Yield % was 3.67%.


China Medical System Holdings  (STU:2M7C) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


China Medical System Holdings Shareholder Yield % Related Terms


China Medical System Holdings Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for China Medical System Holdings's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Medical System Holdings Shareholder Yield % Chart

China Medical System Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 4.01 6.32 6.65 3.21

China Medical System Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.32 10.63 6.65 4.00 3.21

STU:2M7C vs ZTS: Shareholder Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings Shareholder Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's Shareholder Yield % falls into.


STU:2M7C
76GF Score
China Medical System Holdings Ltd STU:2M7C
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Medical System Holdings Shareholder Yield % Calculation

China Medical System Holdings's Shareholder Yield % for the quarter that ended in Dec. 2025 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=2.37 %+0.00 %+1.25 %
=3.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 3.67% mean?
China Medical System Holdings (STU:2M7C) has a Shareholder Yield % of 3.67% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on China Medical System Holdings and its competitors. This is near median its historical median of 4.00. According to the industry distribution chart, China Medical System Holdings ranks #244 out of 971 companies in the Drug Manufacturers industry, placing it in the top 25.1%.
Is China Medical System Holdings' Shareholder Yield % too high?
China Medical System Holdings' current Shareholder Yield % of 3.67% is near median its 10-year median of 4.00. The Drug Manufacturers industry median Shareholder Yield % is 0.28. China Medical System Holdings' value of 3.67% is 1210.7% above this industry median. Based on the distribution chart, China Medical System Holdings ranks #244 out of 971 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, China Medical System Holdings has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' Shareholder Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Medical System Holdings ranks #244 out of 971 companies for Shareholder Yield %. This puts China Medical System Holdings in the upper half of its industry. The industry median Shareholder Yield % is 0.28. China Medical System Holdings' value of 3.67% is 1210.7% above this benchmark. While the company's 10-year median is 4.00 vs. the industry median of 0.28, China Medical System Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.28, based on 971 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Medical System Holdings's current Shareholder Yield % of 3.67% is 1210.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on China Medical System Holdings and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Medical System Holdings's current Shareholder Yield % is 3.67%, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (STU:2M7C) is currently considered Fairly Valued. The stock's GF Value™ is €1.36, compared to a current price of €1.32 — trading 2.9% below its estimated fair value. The current Shareholder Yield % is 3.67%, which is near median its 10-year median of 4.00 and 1210.7% above the Drug Manufacturers industry median of 0.28. China Medical System Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For China Medical System Holdings (STU:2M7C), the current Shareholder Yield % is 3.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Medical System Holdings (STU:2M7C) Overvalued in 2026?

Based on GuruFocus' analysis, China Medical System Holdings stock appears to be undervalued. The current stock price of €1.32 is trading 2.9% below its estimated GF Value™ of €1.36. GuruFocus considers China Medical System Holdings to be Fairly Valued.

Key valuation signals for STU:2M7C:

  • Shareholder Yield %: 3.67% (near median its 10-year median of 4.00)
  • GF Value™: €1.36 vs. price of €1.32 (2.9% below fair value)
  • GF Score™: 76/100 with 3 warning signs
  • Industry Position: 1210.7% above the Drug Manufacturers median (#244 of 971)

No single metric tells the full story. See the STU:2M7C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Medical System Holdings Business Description

Address 510 King’s Road, Unit 2106, 21st Floor, Island Place Tower, North Point, Hong Kong, HKG
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
76GF Score

Get the complete analysis for STU:2M7C

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.32
Price
€1.36
GF Value